Effect of the chemokine receptor CCR5 in the development of American cutaneous leishmaniasis in a Southern Brazilian population

Ribas,Adriana  Danmvolf; Ribas,Rejane   Cristina; Da Silva ,Waldir   Veríssimo; Aristides,Sandra  Mara Alessi; Lonardoni,Maria  Valdrinez Campana; Watanabe,Maria  Angélica Ehara; Borelli,Sueli   Donizete; Silveira,Thaís  Gomes Verzignassi

doi:10.3892/mmr.2013.1452

Effect of the chemokine receptor CCR5 in the development of American cutaneous leishmaniasis in a Southern Brazilian population

Authors:
- Adriana Danmvolf Ribas
- Rejane Cristina Ribas
- Waldir Veríssimo Da Silva
- Sandra Mara Alessi Aristides
- Maria Valdrinez Campana Lonardoni
- Maria Angélica Ehara Watanabe
- Sueli Donizete Borelli
- Thaís Gomes Verzignassi Silveira
View Affiliations

Affiliations: Postgraduate Program in Health Sciences, State University of Maringá, Maringá, Paraná 87020‑900, Brazil, Department of Biostatistics, State University of Maringá, Maringá, Paraná 87020‑900, Brazil, Laboratory of Leishmaniasis, Department of Clinical Analyses and Biomedicine, State University of Maringá, Maringá, Paraná 87020‑900, Brazil, Department of Pathological Sciences, State University of Londrina, Londrina, Paraná 86051-990, Brazil, Laboratory of Immunogenetics, Department of Basic Health Sciences, State University of Maringá, Maringá, Paraná 87020‑900, Brazil
Published online on: April 30, 2013 https://doi.org/10.3892/mmr.2013.1452
Pages: 189-194

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

American cutaneous leishmaniasis (ACL) shows a wide spectrum of clinical and immunopathological manifestations. The CCR5 chemokine receptor directs the immune response to a Th1 pattern and the mutant allele of this genotype (Δ32/Δ32) results in a less effective response, thus leading to a milder inflammation. The objective of the present study was to investigate the effect of the CCR5 chemokine receptor in the pathogenesis of ACL in a population of Southern Brazil. The frequency of the genotypes and their association with ACL were studied in 111 patients and compared with 218 control subjects. Genotyping was performed using samples amplified by polymerase chain reaction with sequence specific primers (PCR‑SSP). The groups varied in chronological age (P<0.00001), but showed no differences in gender (P=0.0696) or ethnicity (P=0.2944). The frequency of the CCR5/Δ32 genotype did not differ between the patient and control groups (P=0.3009). The Δ32/Δ32 deletion was not observed in any individual involved in the study. The analysis of the genotypes observed no significant difference in the frequency of the CCR5/Δ32 genotype between the ACL and control groups, however the subgroup of patients with a recurrence of the lesion showed a higher frequency of the CCR5/Δ32 mutation (P=0.020), indicating a possible effect of this allele in the pathogenesis of ACL. Nevertheless, more studies are required to elucidate the role of CCR5 in the pathogenesis of ACL.

View Figures

View References

1	Rey L: Leishmania and leishmaníases: parasites. Parasitology, Editora Guanabara Koogan. 3rd edition. Rio de Janeiro: pp. 214–226. 2001
2	Condino MLF, Galati EAB, Holeman MM, Salum MRB, Silva DC and Junior RAN: American cutaneous leishmaniasis on the northern coastline of São Paulo, 1993 to 2005. Rev Soc Bras Trop Med. 41:635–641. 2008.(In Portuguese).
3	Gontijo CMF and Melo MN: Visceral leishmaniasis in Brazil: current status, challenges and prospects. Rev Bras Epidemiol. 7:338–349. 2004.(In Portuguese).
4	Gontijo B and de Carvalho Mde L: American cutaneous leishmaniasis. Rev Soc Bras Med Trop. 36:71–80. 2003.(In Portuguese).
5	Pan American Health Organization. Leishmaniasis: 2007 update. http://www.paho.org/English/AD/DPC/CD/leish-2007.pdf. Accessed Feb 09, 2012
6	Guerra JAO, Barbosa MGV, Loureiro ACSP, Coelho CP, Rosa GG and Coelho LIACR: American cutaneous leishmaniasis in children: epidemiological aspects of cases treated in Manaus, Amazonas, Brazil. Rep Public Health. 23:2215–2223. 2007.(In Portuguese).
7	Lima AP, Minelli L, Teodoro U and Comunello E: Distribution of cutaneous leishmaniasis by orbital remote sensing images, in Paraná State, Brazil. An Bras Dermatol. 77:681–692. 2002.
8	Brasil: Ministério da Saúde: Vigilância Epidemiológica. 2012, http://portal.saude.gov.br/portal/saude/profissional/area.cfm?id_area=1560. Accessed Feb 09, 2012
9	Alexander J and Bryson K: T helper (h)1/Th2 and Leishmania: paradox rather than paradigm. Immunol Letters. 99:17–23. 2005. View Article : Google Scholar : PubMed/NCBI
10	Abbas AK: Cytokines. Cellular and Molecular Immunology. Abbas AK, Lichtman AH and Pillai S: 6th edition. Elsevier; Rio de Janeiro: pp. 267–302. 2008
11	Murphy PM: The molecular biology of leukocyte chemoattractant receptors. Annu Rev Immunol. 12:593–633. 1994. View Article : Google Scholar : PubMed/NCBI
12	Baggiolini M: Chemokines and leukocyte traffic. Nature. 392:565–568. 1998. View Article : Google Scholar : PubMed/NCBI
13	Proost P, Wuyts A and van Damme J: The role of chemokines in inflammation. Int J Clin Lab Res. 26:211–223. 1996. View Article : Google Scholar
14	Pereira AB, Rezende NA, Teixeira AL Jr, et al: Cytokines and chemokines in renal transplantation. J Bras Nefrol. 31:286–296. 2009.(In Portuguese).
15	Spagnolo P, Renzoni EA, Wells AU, et al: C-C chemokine receptor 5 gene variants in relation to lung disease in sarcoidosis. Am J Respir Crit Care Med. 172:721–728. 2005. View Article : Google Scholar : PubMed/NCBI
16	Guignard F, Combadiere C, Tiffany HL and Murphy PM: Gene organization and promoter function for CC chemokine receptor 5 (CCR5). J Immunol. 160:985–992. 1998.PubMed/NCBI
17	Liu R, Paxton WA, Choe S, et al: Homozygous defect in HIV-1 coreceptor accounts for resistence of some multiply-exposed individuals to HIV-1 infection. Cell. 86:367–377. 1996. View Article : Google Scholar : PubMed/NCBI
18	Yang X, Ahmad T, Gogus F, et al: Analysis of the CC chemokine receptor 5 (CCR5) Delta32 polymorphism in Behçet’s disease. Eur J Immunogenet. 31:11–14. 2004.
19	Sidoti A, D’Angelo R, Rinaldi C, et al: Distribution of the mutated delta32 allele of the CCR5 gene in a Sicilian population. Int J Immunogenet. 32:193–198. 2005. View Article : Google Scholar : PubMed/NCBI
20	Chies JA and Hutz MH: High frequency of the CCR5delta32 variant among individuals from an admixed Brazilian population with sickle cell anemia. Braz J Med Biol Res. 36:71–75. 2003. View Article : Google Scholar : PubMed/NCBI
21	Zúñiga JA, Villarreal-Garza C, Flores E, et al: Biological relevance of the polymorphism in the CCR5 gene in refractory and non-refractory rheumatoid arthritis in Mexicans. Clin Exp Rheumatol. 21:351–354. 2003.PubMed/NCBI
22	Fildes JE, Walker AH, Howlett R, et al: Donor CCR5 Delta32 polymorphism and outcome following cardiac transplantation. Transplant Proc. 37:2247–2249. 2005. View Article : Google Scholar : PubMed/NCBI
23	GenBank. http://www.ncbi.nlm.nih.gov/nuccore/AF009962. Accessed Apr 05, 2010
24	Silveira TG, Arraes SM, Bertolini DA, Teodoro U, et al: The laboratory diagnosis of epidemiology of cutaneous leishmaniasis in Paraná State, southern Brazil. Rev Soc Bras Med Trop. 32:413–423. 1999.(In Portuguese).
25	Galvani AP and Novembre J: The evolutionary history of the CCR5-Delta32 HIV-resistance mutation. Microbes Infect. 7:302–309. 2005. View Article : Google Scholar
26	Stanford Medicine Schoool. http://www.thetech.org/genetics/news.php?id=13. Accessed Feb 12, 2012
27	Lamb A: CCR5-delta32: a very beneficial mutation. J Creation. 20:152006.
28	Pereira AB, Rao NA, Teixeira AL Jr, Teixeira MM and Silva ACS: Cytokines and chemokines in renal transplantation. J Bras Nefrol. 31:286–296. 2009.(In Portuguese).
29	Li H, Xie HY, Zhou L and Zheng SS: Lack of association of the polymorphism of the CCR5 gene in liver recipients with acute rejection from China. Exp Clin Transplant. 9:252–257. 2011.PubMed/NCBI
30	Oliveira KB, Reiche EMV, Morimoto HK, et al: Analysis of the CC chemokine receptor 5 delta32 polymorphism in a Brazilian population with cutaneous leishmaniasis. J Cutan Pathol. 34:27–32. 2007. View Article : Google Scholar : PubMed/NCBI
31	Muxel SM, Borelli SD, Amarante MK, et al: Association study of CCR5 delta 32 polymorphism among the HLA-DRB1 Caucasian population in Northern Paraná, Brazil. J Clin Lab Anal. 22:229–233. 2008.PubMed/NCBI
32	Passos GA Jr and Picanço VP: Frequency of the delta CCR5 deletion allele in the urban Brazilian population. Immunol Lett. 61:205–207. 1998. View Article : Google Scholar : PubMed/NCBI
33	Leboute AP, de Carvalho MW and Simões AL: Absence of the deltaCCR5 mutation in indigenous populations of the Brazilian Amazon. Hum Genet. 105:442–443. 1999. View Article : Google Scholar : PubMed/NCBI
34	Martinson JJ, Chapman NH, Rees DC, Liu YT and Clegg JB: Global distribution of the CCR5 gene 32-basepair deletion. Nature Genet. 16:100–103. 1997. View Article : Google Scholar : PubMed/NCBI
35	Brasil. Ministério da Saúde. Manual de vigilância da leishmaniose tegumentar Americana. Brasília, DF: pp. 1812007